Moberg Pharma
8,14
SEK
-1,45 %
Mindre end 1K følgere
MOB
NASDAQ Stockholm
Biotechnology & Pharmaceuticals
Health Care
Overview
Finansielt overblik og estimater
Ownership
-1,45%
-14,76%
-19,96%
-47,42%
-71,58%
-49,44%
-74,91%
-87,02%
-86,38%
Moberg Pharma is a Swedish pharmaceutical company focused on the commercialization of proprietary medicines based on proven substances. The company mainly works in nail fungus, where Moberg Pharma is developing a new external treatment. The company has agreements with commercial partners on site in Europe and Asia, among other places. The head office is in Bromma.
Læs mereMarkedsværdi
389,74 mio. SEK
Aktieomsætning
1,61 mio. SEK
Omsætning
9,81 mio.
EBIT %
-3.311,21 %
P/E
-
Udbytteafkast, %
-
Finanskalender
13.5
2025
Delårsrapport Q1'25
22.5
2025
Generalforsamling '25
12.8
2025
Delårsrapport Q2'25
ViserAlle indholdstyper
Moberg Pharma Year-end report 2024
Moberg Pharma: Terclara (MOB-015) is now being launched in Norway
Join Inderes community
Don't miss out - create an account and get all the possible benefits
Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools